Effect and mechanism of jianpishengxue tablet on renal anemia
- Conditions
- Renal anemia in chronic kidney disease
- Registration Number
- ITMCTR2100004868
- Lead Sponsor
- Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
1. Aged 18 to 75 years;
2. Gender: Male or female;
3. Hemoglobin was lower than normal but > 90g/L, and TSAT < 25% and ferritin < 200µg/L;
4. Patients with chronic kidney disease and non-dialysis.
1. Those who had used intravenous iron, oral iron or EPO within one month before inclusion;
2. Suffer from hemochromatosis or hemosiderosis;
3. Suffer from acute or chronic infectious diseases (such as cold, hepatitis, etc.), tumors, and diseases of the blood system;
4. Patients with peptic ulcer, ulcerative enteritis, pancreatitis, intestinal inflammation and alcoholism;
5. Patients who are allergic to or have allergies to this drug;
6. Poor nutritional status within one month before enrollment;
7. Patients undergoing other intervention clinical studies at the same time;
8. Pregnant women and lactating women.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Ferritin;Blood routine examination;Interleukin-6;Transferrin saturation;Erythropoietin;Cystatin C;Hepcidin;High-sensitivity C-reactive protein;Renal function;
- Secondary Outcome Measures
Name Time Method